IVTM Intravascular Temperature

TM

Management

IVTM for Perioperative Burn Management

Reliable, Consistent Temperature Control
Efficient, Steady IVTM Protects
Burn victims are at high risk of hypothermia and,
if left unmanaged, can be associated with increased
mortality and morbidity. 1, 2
Hypothermia occurs at all stages of a burn
patient’s treatment. Therefore, symptoms must be
monitored and managed throughout the entire
recovery process.
ZOLL’s Intravascular Temperature Management System
(IVTM) provides efficient, reliable, and effective
hypothermia management in burn patients -- before,
during, and post surgery.
The most notable benefit of IVTM is
that since it warms from the core,
surgeons and staff are not
subject to working in
uncomfortable
conditions.
Risks Associated with Hypothermia
Pre-Operative
■ When burned, a body cannot self-regulate
temperature because the skin loses its insulator
function. Heat loss is further compromised by large
infusions of fluid and moist dressings.3
■ A drop of 1.9°C triples the incidence of surgical
wound infections and increases hospitalization
by 20 percent.4
During Surgery
■ Hypothermia is seen in approximately 89 percent
of burn surgeries, and can disrupt coagulation,
platelet function, and immunological function as
well as depress metabolic and cardio-respiratory
function in patients.5
■ Burn patients are at higher risk of developing
hypothermia in the operating room if they are
anesthetized, since anesthesia blunts metabolic
and neurologic response.6
■ Heat loss from surgical interventions, such as
wound excision and debridement, can further
aggravate hypothermia. The percentage of
debridement during surgery can, in turn, be limited
by blood loss and/or hypothermia.7
Post-Operative
■ If patients cannot generate heat, they are
unable to produce additional energy to overcome
sepsis and promote wound healing.1
■ Hypothermia averaging 1.5°C less than
normal can result in cumulative adverse
outcomes, adding between $2,500 and
$7,000 per surgical patient.6
Against Hypothermia
Perioperative Temperature Management
Maximized
By incorporating ZOLL’s IVTM into the full treatment
process, patients, surgeons, and staff will benefit.
Warm saline is
circulated
Normothermia is maintained. Starting the warming
within a
process intravascularly prior to surgery, patients are
closed-loop
able to quickly reach and maintain normothermia
multi-balloon
throughout the treatment process. When patients are
catheter. The patient is
normothermic, conditions such as bleeding and warmed as venous blood passes over each balloon.
infections are better managed and decreases length The process is rapid and precise, offering unlimited
of stary.4, 6, 8 patient access and minimal nursing time.

Surgery time is
maximized by
maintaining patient Benefits of IVTM for Burn Treatment
temperature through
ZOLL’s IVTM.
■
Patients are quickly warmed
■
Patient normothermia is maintained
perioperatively
Surgery time is maximized. Traditionally, burn ■
Patient access is maximized
patients require multiple operations for excision and ■
Surgery time is augmented
grafting of large burn wounds. With IVTM, ■
Postoperative temperature spikes are
surgeons can accomplish more procedures during reduced, continuous
each operation, potentially decreasing the number care is increased
of surgeries, length of stay, and costs.9 ■
Surgeons and staff
work in a
Temperature and care is stabilized. Postoperatively, comfortable
temperature spikes can be managed and care can environment
be continuous through IVTM’s precise temperature
control method.8

Comfort level in OR is increased. Since IVTM

warms from the core, surgeons and staff are not
subjected to working in uncomfortable conditions.9
ZOLL’s IVTM Outperforms Other Conventional Warming Methods

Conventional Warming Methods Intravascular Warming

(Blankets, fluids, lamps, room temperature) (IVTM™)

Control of Target Temperature • Causes temperature decrease of more Maintains tight temperature
than 1°C in 62.5% in patients and control (±0.2°C) throughout
more than 2°C in 25% of patients.10 treatment period.11
• Experiences rebound hypothermia
post-operatively.
• Needs large amounts of warm fluid.

Time-to-Target Temperature .50°C/hr11 1.53°C/hr11

Surgery Time Two-staged excision recommended.7 Maximizes surgery time and

saves costs.9

Patient Access Difficult to place blankets over Minimal disruption.

burn wounds.

Nursing Time Requires management throughout • System maintains itself

treatment. automatically after target
temperature is set.
• Requires no care of blankets,
fluid infusion management, etc.

OR Environment Creates uncomfortable work Provides comfortable work

environment (+85°F)9 environment (75°F)9

1
Branas, Bravo et al. Hypothermia and Burns: A Meta-analysis. Annals
of Burns and Fire Disasters. Vol. XVI. No. 2. June 2003.
2
Jurkovich GJ, et al. Hypothermia in trauma victims: an ominous predictor
of survival. J Trauma. 27(9):1019-24. 1987 Sept.
3
Luna, G et al. Incidence and Effect of Hypothermia in Seriously Injured
Patient. J Trauma. 27(9):1014-18. 1987 Sept.
4
Kurz A, et al. Perioperative Normothermia to Reduce the Incidence
of Surgical-Wound Infection and Shorten Hospitalization. The New
England Journal of Medicine. Vol. 334, No. 19 pp 1209-15.
May 1996.
5
Trauma Care. Volume 15, Number 4, Fall 2005. Metabolic Consequences
of the “Lethal Triad” or Bloody Vicious Cycle.
6
Mahoney, C et al. Maintaining intraoperative normothermia:
A meta-analysis of outcomes with costs. AANA Journal. April 1999. Vol. 67,
No. 2, pp 155-63.
7
Warden GD, et al. A two-stage technique for excision and grafting of burn
wounds. J Trauma, 1982, Feb;22(2):98-103.
8
Schulman MD MSPH FACS, Carl. 2007 ABA presentation.
9
Corallo, J et al. Core warming of a burn patient
during excision to prevent hypothermia. Burns 34 (2008)
418-420.
10
Oda MD, Jun. Hypothermia During Burn Surgery and
Postopertive Acute Lung Injury in Extensively Burned
Patients. J Trauma. 2009;66:1525-1530.
11
Taylor MD, Edward et al. Active intravascular rewarming
for hypothermia associated with traumatic injury: early
experience with a new technique. Baylor University
Medical Center Proceedings. 2008;2(2): 120-126.

ZOLL Medical Corporation (NASDAQ: GS) is the world leader in resuscitation technologies for ZOLL Medical Corporation
hospitals with advanced solutions that increase clinical and operational efficiency and enhance patient Worldwide Headquarters
care. From early intervention through post-resuscitation care, ZOLL’s innovative technologies, including 269 Mill Road
Real CPR Help® and See-Thru CPR®, help clinicians provide CPR, defibrillation, and ALS care with Chelmsford, MA 01824
confidence; simplify device operation; and capture and analyze vital patient data. ZOLL also develops 978-421-9655
market-leading temperature control therapies that enable powerful and precise temperature 800-348-9011
management for critical care and surgical patients. www.zoll.com

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company, ZOLL develops
and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, For subsidiary addresses and
Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 fax numbers, as well as other
business partners, and 200 independent representatives serve our customers in over 140 countries global locations, please go to
around the globe. For more information, visit www.zoll.com. www.zoll.com/contacts.

Printed in U.S.A. 031010 ©2011 ZOLL Medical Corporation. All rights reserved. IVTM and ZOLL are
104170-001A4 trademarks or registered trademarks of ZOLL in the United States and/or other countries.
9656-0220 All trademarks are the property of their respective owners.